Clinical Trials on Obesity in Czechia

Total 56 results

Faculty Hospital Kralovske Vinohrady

Recruiting

CArdioMetabolic Prevention in Adolescents (CAMP)

Body Weight Changes | Adolescent Obesity | Life Style, Healthy | Cardiometabolic Syndrome

Czechia
Endobar Solutions LLC
Na Homolce Hospital; OB KLINIKA a.s. Pod Krejcárkem 975 Praha 3 - Žižkov Tel... and other collaborators

Completed

The Lowering Weight in Severe Obesity by Embolization of the Gastric Artery Trial (LOSEIT)

Obesity, Morbid

Czechia
University Hospital Ostrava
University of Ostrava; Vítkovice Hospital Ostrava, Czech Republic

Completed

Aspiration Therapy for Obese Adolescents

Obesity, Morbid

Czechia
St. Anne's University Hospital Brno, Czech Republic

Completed

Relationship Between Normal-weight Central Obesity and Obstructive Sleep Apnea

Sleep Disorder | Body Fat Distribution

Czechia
University Hospital Ostrava
University of Ostrava

Completed

Bariatric Surgery and Fatty Liver Disease

Hypertension | Diabetes | Morbid Obesity

Czechia
ENDOPLY
Just 4 Device s.r.o.

Not yet recruiting

ENDOPLY System in Humans: a Pilot Study

Obesity

Czechia
Spatz FGIA, Inc

Completed

A Study to Compare the 12-month Spatz3 Adjustable Balloon With a 6-month Non Adjustable Balloon

Overweight and Obesity

Czechia
Charles University, Czech Republic
Ministry of Health, Czech Republic; EXCELES LX22NPO5104, CarDia

Recruiting

Metabolic Flexibility to Predict Lifestyle Interventions Outcomes (MEPHISTO)

Obesity

Czechia
Institute for Clinical and Experimental Medicine

Not yet recruiting

Laparascopic Sleeve Gastrectomy vs. Endoscopic Gastric Plication in Obesity (SLAVIA)

Obesity

Czechia
Charles University, Czech Republic
Institut National de la Santé Et de la Recherche Médicale, France; Faculty...

Completed

De Novo Lipogenesis and Insulin Sensitivity in Obese (DELISA)

Obesity | Insulin Resistance

Czechia
Martin Haluzik

Recruiting

Effect of Complex Weight-reducing Interventions on Rhythm Control in Obese Subjects With Atrial Fibrillation (HOBIT-FS)

Obesity | Atrial Fibrillation

Czechia
University of Ostrava

Completed

The Effects of Lowering Dietary Carbohydrates on Health, Exercise Performance and Wellbeing-related Outcomes

Obesity | Diet Modification

Czechia
Nitinotes Surgical Ltd.

Active, not recruiting

Evaluation of Health Improvement in Obese Patients With Obesity-related Comorbidities Followed by EndoZip Procedure (CL00010)

Obesity

Italy, Czechia
University of Ostrava
University Hospital Ostrava; University Hospital Olomouc; Palacky University

Recruiting

Bariatric Endoscopy and NAFLD

Obesity | NAFLD | Liver Steatosis | Liver Fibrosis

Czechia
GT Metabolic Solutions, Inc.

Recruiting

Magnetic Jejuno-Ileal Diversion Study ("MJI Study")

Obesity | Type 2 Diabetes

Czechia
Gelesis, Inc.

Completed

Effect of GSP3 on Body Weight in Overweight and Obese Subjects (FLOW)

Obesity | Overweight

Italy, Denmark, Czechia
Vitadio s.r.o.
University Hospital Olomouc

Completed

Impact of Digital Therapeutic on Metabolic Parameters

Obesity | Diabetes Mellitus, Type 2 | Insulin Resistance | Prediabetic State

Czechia
University of Ostrava
Institute for Clinical and Experimental Medicine; Vitkovice Hospital

Active, not recruiting

Small Bowel Diversion

Obesity | Type2 Diabetes

Czechia
Faculty Hospital Kralovske Vinohrady

Recruiting

Novel Inhibitors of Lipolysis in the Treatment of Lipid a Glucose Metabolism in Obstructive Sleep Apnea Syndrome (NORRIS)

Obesity | Obstructive Sleep Apnea

Czechia
Nemocnice Břeclav, p.o.

Unknown

Roux-en-Y Gastric Bypass (RYGB) Versus Omega-Loop Gastric Bypass (OLGB) Safety and Efficacy Short-term Study (ROSESS)

Diabetes Mellitus, Type 2 | Obesity, Severe

Czech Republic
University Hospital Ostrava
University of Ostrava; Clínica Opcíon Médica Barcelona; Optimal Clinic Tel Aviv

Completed

Adjustable Balloons for Weight Loss: A Higher Yield of Responders Compared With Non-Adjustable Balloons

Obesity

Czechia, Israel, Spain
University Hospital Ostrava

Active, not recruiting

Bariatric Endoscopy and NAFLD

Obesity | NAFLD | Liver Steatosis | Liver Fibrosis

Czechia
Ethicon Endo-Surgery

Terminated

Surgical Intervention in Bariatric Patients: Excess Weight Loss in the Morbidly Obese Following Gastric Plication

Morbid Obesity

United States, Czech Republic
Ethicon Endo-Surgery

Completed

Six-month Study to Compare the Effects of Volume- and Pressure-Guided Adjustments on Weight Loss and Satiety

Morbid Obesity

Czech Republic, Australia
University Hospital Ostrava
University of Ostrava; Vitkovice Hospital, Ostrava, Czech Republic

Completed

Metabolic Changes After Bariatric Surgery

Type 2 Diabetes Mellitus | Grade III Obesity

Czechia
Saniona

Completed

Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS) (2016-003694-18)

Confirmed Genetic Diagnosis of Prader-Willi Syndrome

Czechia, Hungary
Ethicon Endo-Surgery

Completed

A Trial of the Jejunal Diversion Procedure

Obesity | Diabetes

Czech Republic
Allurion Technologies

Unknown

Pilot Trial of the Elipse™ Intragastric Balloon System for the Treatment of Overweight and Obese Individuals

Obesity | Overweight

Czech Republic, Greece
Charles University, Czech Republic

Completed

Role of Adipose Tissue in Pathogenesis of Insulin Resistance

Obesity | Insulin Resistance

Czech Republic
Gelesis, Inc.

Completed

Extension Study of Gelesis100 on Body Weight (GLOW-EX)

Overweight and Obesity

United States, Czechia, Denmark, Italy, Spain
Novo Nordisk A/S

Completed

A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland (ExplorEUEast)

Obesity

Poland, Czechia, Hungary
Bispebjerg Hospital
World Health Organization; International Network of Health Promoting Hospitals... and other collaborators

Completed

WHO-HPH Recognition Project on Fast-Track Implementation of Clinical Health Promotion (RP)

Smoking | Obesity | Malnutrition | Excessive Drinking | Lack of Physical Activity

Canada, Croatia, Czechia, Denmark, Estonia, Indonesia, Japan, Malaysia, Slovenia, Taiwan, Thailand
Novo Nordisk A/S

Completed

The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes

Obesity | Metabolism and Nutrition Disorder

Spain, Denmark, Sweden, Belgium, Finland, Netherlands, United Kingdom, Czechia
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults

Obesity | Overweight

Austria, United Kingdom, United States, Slovakia, Hungary, Czechia, Canada
Sanofi

Terminated

Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood Glucose (PRADO)

Obesity

France, Canada, Brazil, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Bulgaria, Slovakia, Belgium, Czech Republic, Austria, Denmark, Egypt, Finland, Greece, Hungary, Ireland, Israel, Italy, Lithuania, Luxembourg, Mexico, Norway, United Kingdom
Gelesis, Inc.

Completed

Study of Gelesis100 on Body Weight in Overweight and Obese Subjects With and Without Type 2 Diabetes

Obesity | Overweight

United States, Canada, Czechia, Denmark, Italy, Spain
Sanofi

Terminated

European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia (ETERNAL)

Obesity | Dyslipidemias

Germany, Netherlands, Turkey, Slovakia, United Kingdom, Finland, Hungary, Ireland, Italy, Norway, Greece, Sweden, Czech Republic, Portugal, Switzerland
Eli Lilly and Company

Recruiting

A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Obesity | Overweight

United States, Canada, Italy, Czechia, Israel, Mexico, Poland
Gedeon Richter Plc.

Completed

Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome

Prader-Willi Syndrome

United States, Spain, France, Italy, Czechia
Gelesis, Inc.

Unknown

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes (LIGHT-UP)

Obesity | Diabetes | Overweight | PreDiabetes

United States, United Kingdom, Poland, Hungary, Italy, Canada, Czechia, Denmark
Novo Nordisk A/S

Active, not recruiting

A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) (STEP UP)

Obesity

United States, Czechia, Germany, Canada, Hungary, Portugal, Norway, South Africa, Poland, Greece, Bulgaria, Slovakia
Sanofi

Completed

Obese Patients With Type 2 Diabetes (RIO-Diabetes)

Obesity | Diabetes Mellitus, Non-Insulin-Dependent | Obesity in Diabetes

United States, France, Canada, Poland, Germany, Netherlands, Belgium, Czech Republic, Argentina, Finland, United Kingdom
Eli Lilly and Company

Recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES)

Overweight and Obesity

United States, Australia, Italy, Hungary, Netherlands, Canada, France, Spain, United Kingdom, Germany, Argentina, Czechia, Israel, Austria, Belgium, Greece, Turkey, Mexico, Romania, Brazil, India, Slovakia, Poland, Puerto Rico, Denmark
Novo Nordisk A/S

Completed

Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity (STEP-HFpEF)

Obesity

United States, Spain, Australia, Hungary, United Kingdom, Netherlands, Canada, Argentina, Czechia, Germany, Denmark, Israel, Poland
Pfizer

Terminated

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

Obesity

United States, Australia, Canada, Brazil, Slovakia, Czech Republic, Argentina, Germany, Mexico, United Kingdom, Sweden
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO)

Obesity | Overweight

Spain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Netherlands, Korea, Republic... and more
Pfizer

Terminated

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

Obesity | Diabetes Mellitus

United States, Hungary, Canada, Japan, Poland, Puerto Rico, Bulgaria, Czechia
Novo Nordisk A/S

Completed

Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity (SELECT)

Obesity | Overweight

United States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
Novo Nordisk A/S

Recruiting

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

Obesity | Diabetes Mellitus, Type 2

United States, Spain, Portugal, Italy, Greece, Romania, Czechia, Slovakia, South Africa, Ukraine
Boehringer Ingelheim
Eli Lilly and Company

Completed

Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus

Obesity | Diabetes Mellitus, Type 2

United States, Belgium, Bulgaria, Colombia, Czech Republic, Finland, France, Germany, Guatemala, Mexico, Peru, Russian Federation, Spain, Ukraine

Clinical Trials on Obesity in Czechia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations